3,4-Dihydroxyphenylacetaldehyde
Names | |
---|---|
Preferred IUPAC name
(3,4-Dihydroxyphenyl)acetaldehyde | |
Other names
2-(3,4-Dihydroxyphenyl)acetaldehyde[1] Dopaldehyde | |
Identifiers | |
3D model (JSmol) |
|
3DMet | B00668 |
Abbreviations | DOPAL |
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.237.172 |
KEGG | |
MeSH | 3,4-dihydroxyphenylacetaldehyde |
PubChem CID |
|
| |
| |
Properties | |
C8H8O3 | |
Molar mass | 152.15 g·mol−1 |
Density | 1.306 g/mL |
Boiling point | 351 °C (664 °F; 624 K) |
Related compounds | |
Related 2-phenyl aldehydes |
Phenylacetaldehyde |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
3,4-Dihydroxyphenylacetaldehyde (DOPAL) is a metabolite of the neurotransmitter dopamine. DOPAL is an important precursor of the major brain metabolites of dopamine, 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxy-phenylacetic acid. DOPAL plays a role in Parkinson's disease.[2] DOPAL has been chemically synthesized.[3]
References
- ↑ "3,4-dihydroxyphenylacetaldehyde - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 24 June 2005. Identification and Related Records. Retrieved 13 October 2011.
- ↑ Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y., "Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease," J Neurochem. 2013 Sep;126(5):591-603.
- ↑ Li, W., Spaziano, V.T., Burke, WJ., "Synthesis of a biochemicallly important aldehyde - 3,4-dihydroxyphenylacetaldehyde", Bio-Organic Chemistry, 26, 45-50, 1998.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.